NeuroOne Medical Technologies Corporation (NMTC) financial statements (2021 and earlier)

Company profile

Business Address 7599 ANAGRAM DR
EDEN PRAIRIE, MN 55344
State of Incorp. DE
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
9/30/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,04426126 201
Cash and cash equivalents2,04426126 201
Prepaid expense48417    
Disposal group, including discontinued operation   4   
Total current assets:2,092302344201
Noncurrent Assets
Operating lease, right-of-use asset325 
Property, plant and equipment6852     
Intangible assets, net (including goodwill)173179216   
Intangible assets, net (excluding goodwill)173179216    
Total noncurrent assets:567231216    
TOTAL ASSETS:2,6595332504201
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7811,7701,022221713 
Accounts payable1,1441,152 221710 
Accrued liabilities6366181,022  3 
Debt5,192 2,421 14 28
Due to related parties   745323 
Disposal group, including discontinued operation   22   
Other undisclosed current liabilities  462   3
Total current liabilities:6,9731,7703,905118833631
Noncurrent Liabilities
Long-term debt and lease obligation298      
Operating lease, liability298 
Other undisclosed noncurrent liabilities  1,381    
Total noncurrent liabilities:298 1,381    
Total liabilities:7,2711,7705,287118833631
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,612)(1,238)(5,037)(114)(81)(35)(30)
Common stock141385555
Additional paid in capital17,25015,98828046937746
Accumulated deficit(21,876)(17,239)(5,325)(228)(180)  
Other undisclosed stockholders' equity attributable to parent   64 (117)(81)
Total stockholders' equity:(4,612)(1,238)(5,037)(114)(81)(35)(30)
TOTAL LIABILITIES AND EQUITY:2,6595332504201

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
9/30/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:    111
Operating expenses(6,552)(5,813)(77)(33)(50)(37)(26)
Operating loss:(6,552)(5,813)(77)(33)(49)(36)(25)
Nonoperating expense     (0)(5)
Interest and debt expense(553)(553)(35) (14)  
Loss from continuing operations before equity method investments, income taxes:(7,105)(6,367)(112)(33)(63)(36)(31)
Other undisclosed loss from continuing operations before income taxes(2,823)      
Loss from continuing operations:(9,928)(6,367)(112)(33)(63)(36)(31)
Loss from discontinued operations   (16)   
Loss before gain (loss) on sale of properties:(9,928)(6,367)(112)(48)(63)(36)(31)
Other undisclosed net loss(552)(414)     
Net loss:(10,480)(6,781)(112)(48)(63)(36)(31)
Other undisclosed net income attributable to parent414  0   
Net loss available to common stockholders, diluted:(10,065)(6,781)(112)(48)(63)(36)(31)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
9/30/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(10,480)(6,781)(112)(48)(63)(36)(31)
Comprehensive loss, net of tax, attributable to parent:(10,480)(6,781)(112)(48)(63)(36)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: